Adlan Mohamed A, Premawardhana Lakdasa D
Section of Endocrinology and Diabetes, Department of Medicine, Caerphilly District Miners Hospital, St. Martin's Road, Caerphilly CF83 2WW, UK.
J Thyroid Res. 2011;2011:745135. doi: 10.4061/2011/745135. Epub 2011 Jul 10.
Postpartum thyroid dysfunction (PPTD) is a common disorder which causes considerable morbidity in affected women. The availability of effective treatment for hypothyroid PPTD, the occurrence of the disease in subsequent pregnancies and the need to identify subjects who develop long term hypothyroidism, has prompted discussion about screening for this disorder. There is currently no consensus about screening as investigations hitherto have been variable in their design, definitions and assay frequency and methodology. There is also a lack of consensus about a suitable screening tool although thyroid peroxidase antibody (TPOAb) is a leading contender. We present data about the use of TPOAb in early pregnancy and its value as a screening tool. Although its positive predictive value is moderate, its sensitivity and specificity when used in early pregnancy are comparable or better compared to other times during pregnancy and the postpartum period. Recent studies have also confirmed this strategy to be cost effective and to compare favourably with other screening strategies. We also explore the advantages of universal screening.
产后甲状腺功能障碍(PPTD)是一种常见疾病,会给患病女性带来相当大的健康问题。针对甲状腺功能减退型PPTD有效治疗方法的可得性、该疾病在后续妊娠中的发生情况以及识别出会发展为长期甲状腺功能减退的患者的必要性,引发了关于对此疾病进行筛查的讨论。目前对于筛查尚无共识,因为迄今为止的调查在设计、定义、检测频率和方法上各不相同。对于合适的筛查工具也缺乏共识,尽管甲状腺过氧化物酶抗体(TPOAb)是主要的候选指标。我们展示了关于在妊娠早期使用TPOAb及其作为筛查工具的价值的数据。尽管其阳性预测值中等,但在妊娠早期使用时,其敏感性和特异性与孕期其他时间以及产后时期相比具有可比性或更优。近期研究也证实该策略具有成本效益,且与其他筛查策略相比更具优势。我们还探讨了普遍筛查的优势。